382 related articles for article (PubMed ID: 19024859)
1. [Sildenafil and nitric oxide inhalation in neonatal pulmonary hypertension. Three case reports].
Cavallaro G; Agazzani E; Andaloro L; Bottura C; Cristofori G; Mussini P; Sacco F; Compagnoni G
Pediatr Med Chir; 2008; 30(3):149-55. PubMed ID: 19024859
[TBL] [Abstract][Full Text] [Related]
2. PPHN: is sildenafil the new nitric? A review of the literature.
Spillers J
Adv Neonatal Care; 2010 Apr; 10(2):69-74. PubMed ID: 20386371
[TBL] [Abstract][Full Text] [Related]
3. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.
Matamis D; Pampori S; Papathanasiou A; Papakonstantinou P; Tsagourias M; Galiatsou E; Koulouras V; Nakos G
Circ Heart Fail; 2012 Jan; 5(1):47-53. PubMed ID: 22057829
[TBL] [Abstract][Full Text] [Related]
4. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
[TBL] [Abstract][Full Text] [Related]
5. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study.
Baquero H; Soliz A; Neira F; Venegas ME; Sola A
Pediatrics; 2006 Apr; 117(4):1077-83. PubMed ID: 16585301
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
7. Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.
Khorana M; Yookaseam T; Layangool T; Kanjanapattanakul W; Paradeevisut H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S64-73. PubMed ID: 22043756
[TBL] [Abstract][Full Text] [Related]
8. The use of sildenafil in persistent pulmonary hypertension of the newborn.
Vargas-Origel A; Gómez-Rodríguez G; Aldana-Valenzuela C; Vela-Huerta MM; Alarcón-Santos SB; Amador-Licona N
Am J Perinatol; 2010 Mar; 27(3):225-30. PubMed ID: 19866403
[TBL] [Abstract][Full Text] [Related]
9. [Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
Condò V; Colnaghi MR; Mosca E
Pediatr Med Chir; 2008; 30(3):156-8. PubMed ID: 19024860
[No Abstract] [Full Text] [Related]
10. A comparison of magnesium sulphate and sildenafil in the treatment of the newborns with persistent pulmonary hypertension: a randomized controlled trial.
Uslu S; Kumtepe S; Bulbul A; Comert S; Bolat F; Nuhoglu A
J Trop Pediatr; 2011 Aug; 57(4):245-50. PubMed ID: 20923790
[TBL] [Abstract][Full Text] [Related]
11. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
Lee JE; Hillier SC; Knoderer CA
J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
Noori S; Friedlich P; Wong P; Garingo A; Seri I
Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
[TBL] [Abstract][Full Text] [Related]
13. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension.
Steinhorn RH; Kinsella JP; Pierce C; Butrous G; Dilleen M; Oakes M; Wessel DL
J Pediatr; 2009 Dec; 155(6):841-847.e1. PubMed ID: 19836028
[TBL] [Abstract][Full Text] [Related]
14. [Persistent pulmonary hypertension in premature and newborn infants: selective pulmonary vasodilation with inhaled nitric oxide (iNO)].
Herkenhoff M; Schaible T; Reiss I; Kandzora J; Möller J; Gortner L
Z Geburtshilfe Neonatol; 1998; 202(1):25-9. PubMed ID: 9577919
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil to facilitate weaning from inhaled nitric oxide and mechanical ventilation in a patient with severe secondary pulmonary hypertension and a patent foramen ovale.
Elias S; Sviri S; Orenbuch-Harroch E; Fellig Y; Ben-Yehuda A; Fridlender ZG; Gilon D; Bayya A
Respir Care; 2011 Oct; 56(10):1611-3. PubMed ID: 21513610
[TBL] [Abstract][Full Text] [Related]
16. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
[TBL] [Abstract][Full Text] [Related]
17. Persistent pulmonary hypertension in the newborn: therapeutic effect of sildenafil.
Cruz-Blanquel A; Espinosa-Oropeza A; Romo-Hernández G; Carrillo-Alarcón L; Ponce-Monter H; Ortiz MI
Proc West Pharmacol Soc; 2008; 51():73-7. PubMed ID: 19544683
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil as “first line therapy” in pulmonary persistent hypertension of the newborn?
Nassi N; Daniotti M; Agostiniani S; Lombardi E; Favilli S; Donzelli GP
J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():104-5. PubMed ID: 20836736
[TBL] [Abstract][Full Text] [Related]
19. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).
Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J
Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113
[TBL] [Abstract][Full Text] [Related]
20. Outcome of oral sildenafil in neonatal persistent pulmonary hypertension of non-cardiac causes.
Sayed A; Bisheer N
J Neonatal Perinatal Med; 2015; 8(3):215-20. PubMed ID: 26485555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
